MLSS Stock Analysis: Buy, Sell, or Hold?
MLSS - Milestone Scientific, Inc. Common Stock
$0.47
-0.02 (-4.65%)
▼
5d:
-11.17%
30d:
+14.1%
90d:
+35.48%
WAIT
LOW Confidence
Analysis Updated: Aug 19, 2026 12:00 AM ET
Earnings: Aug 14, 2026
0d
Get Alerted When MLSS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: MLSS is down 11.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: MLSS is down 11.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: MLSS is currently trading at $0.47, which is considered extended relative to its 30-day fair value range of $0.37 to $0.47.
Technical Outlook: Technically, MLSS is in a strong uptrend. Immediate support is located at $0.44, while resistance sits at $0.58. Short-term momentum is weak, with the stock down 4.6% recently.
Market Sentiment: MLSS scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $1.25 (+165.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MLSS is in a strong uptrend. Immediate support is located at $0.44, while resistance sits at $0.58. Short-term momentum is weak, with the stock down 4.6% recently.
Market Sentiment: MLSS scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $1.25 (+165.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$0.37 -
$0.47
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
21.1%
All Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.6%)
- BULLISH: Trading 165.9% below Wall St target ($1.25)
- WARNING: Composite score 46/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.37 -
$0.47
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$0.44
Resistance Level
$0.58
Current Trend
Strong Uptrend
Technical data as of
Aug 19, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-13.43
Wall Street Target
$1.25
(+165.9%)
Revenue Growth (YoY)
22.3%
Profit Margin
-44.0%
Share & Embed Analysis
Last updated: August 20, 2026 12:26 AM ET
Data refreshes hourly during market hours. Next update: 1:26 AM
Data refreshes hourly during market hours. Next update: 1:26 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MLSS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$478 | 37 SELL |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$86 | 30 SELL |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$405 | 58 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$247 | 48 HOLD |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$186 | 35 SELL |
